February 22, 2022 12:09 PM EST
Pharma
Marketing

Mar­ket­ingRx roundup: GSK switch­es up Cabe­nu­va TV ad with new­ly ap­proved dos­ing; AZ de­buts new Breztri TV

Beth Snyder Bulik

Senior Editor

It’s a sub­tle, but key change in Glax­o­SmithK­line’s Vi­iV Health­care Cabe­nu­va TV cam­paign. A new com­mer­cial launched last week be­gins with the ex­act same word­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Bris­tol My­er­s' TYK2 in­hibitor suc­ceeds in pair of Phase 3 pso­ri­at­ic arthri­tis tri­als

A service from the Financial Times